Loading company…

BOSTON SCIENTIFIC CORPORATION

BSXCIK 000088572519 fiscal years, 71 SEC filings

RevenueFY2025

$20.07B19.9%

Net incomeFY2025

$2.90B56.3%

Free cash flowFY2025

$3.66B38.3%

Diluted EPSFY2025

$1.9455.2%

Trends

FY2007–FY2025 · hover a year for its filing

Revenue & net incomeRevenueNet income

revenue 2.4× since FY2007 · net margin -5.9% → 14.4%

MarginsNet marginFCF margin

FY2025: net 14.4% · free cash flow 18.2% of revenue

Cash flowOperating cash flowFree cash flow

FY2025: $4.53B operating cash − $876.0M capex = $3.66B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity -15% (FY2008) → 12% (FY2025) · on assets 6.6%

USD millions, except per-share values; share counts in millions. Click a value to open its filing; hover for the XBRL tag.

USD millions	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Revenue	20,074	16,747	14,240	12,682	11,888	9,913	10,735	9,823	9,048	8,386	7,477	7,462
Net income	2,898	1,854	1,593	—	—	—	4,700	1,671	—	347	(239)	(119)
Diluted EPS	1.94	1.25	1.07	0.45	0.69	(0.08)	3.33	1.19	0.08	0.25	(0.18)	(0.09)
Diluted shares	1,495	1,486	1,464	1,440	1,434	1,417	1,411	1,401	1,393	1,377	1,341	1,324
Operating cash flow	4,534	3,435	2,503	1,526	1,870	1,508	1,836	310	1,426	1,182	691	1,269
Capital expenditures	876	790	711	588	554	376	461	316	319	376	247	259
Free cash flow	3,658	2,645	1,792	938	1,316	1,132	1,375	(6)	1,107	806	444	1,010
Cash & equivalents	1,965	414	865	928	1,925	1,734	217	146	188	196	319	587
Total assets	43,673	39,395	35,136	32,469	32,229	30,777	30,565	20,999	19,042	18,096	18,133	17,024
Shareholders' equity	24,233	21,770	19,282	17,573	16,622	15,326	13,877	8,726	7,012	6,733	6,320	6,457

As reported in SEC filings; a missing tag shows “—”, never zero. Free cash flow is operating cash flow − capex. Methodology